Enhanced rho-kinase activity in circulating neutrophils of patients with vasospastic angina: A possible biomarker for diagnosis and disease activity assessment

Journal of the American College of Cardiology

Volumn 58, Issue 12, 2011, Pages 1231-1237

  Kikuchi, Yoku ^a   Yasuda, Satoshi ^a   Aizawa, Kentaro ^a   Tsuburaya, Ryuji ^a   Ito, Yoshitaka ^a   Takeda, Morihiko ^a   Nakayama, Masaharu ^a   Ito, Kenta ^a   Takahashi, Jun ^a   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

acetylcholine; inflammation; leukocytes; vasospasm

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BINDING PROTEIN; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYOSIN BINDING SUBUNIT; NICORANDIL; NITRATE; RHO KINASE; UNCLASSIFIED DRUG;

ADULT; ANGINA PECTORIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY SPASM; DISEASE ACTIVITY; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PHARMACOLOGIC STRESS TESTING; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SMOKING; THORAX PAIN; VASOSPASM; VASOSPASTIC ANGINA PECTORIS;

AGED; ANGINA PECTORIS; BIOLOGICAL MARKERS; CORONARY VASOSPASM; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; RHO-ASSOCIATED KINASES;

EID: 80052848443     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.05.046     Document Type: Article

References (40)

1. A. Maseri, A. L'Abbate, and G. Baroldi Coronary vasospasm as a possible cause of myocardial infarctiona conclusion derived from the study of preinfarction angina N Engl J Med 299 1978 1271 1277 (Pubitemid 9115796)
2. M. Nakamura, A. Takeshita, and Y. Nose Clinical characteristics associated with myocardial infarction, arrhythmias, sudden death in patients with vasospastic angina Circulation 75 1987 1110 1116 (Pubitemid 17081016)
3. H. Shimokawa, K. Nagasawa, and T. Irie Clinical characteristics and long-term prognosis of patients with variant angina A comparative study between Western and Japanese populations Int J Cardiol 18 1988 331 349 (Pubitemid 18045276)
4. R.J. Myerburg, K.M. Kessler, and S.M. Mallon Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm N Engl J Med 326 1992 1451 1455
5. A. Maseri, J.F. Beltrame, and H. Shimokawa Role of vasoconstriction in ischemic heart disease and search for novel therapeutic targets Circ J 73 2009 394 403
6. H. Yasue, Y. Mizuno, E. Harada, T. Itoh SCAST (Statin and Coronary Artery Spasm Trial) Investigators Effect of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers J Am Coll Cardiol 51 2008 1742 1748 (Pubitemid 351608498)
7. N. Katsumata, H. Shimokawa, and M. Seto Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1b Circulation 96 1997 4357 4363 (Pubitemid 28007466)
8. H. Shimokawa, M. Seto, and N. Katsumata Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm Cardiovasc Res 43 1999 1029 1039 (Pubitemid 29413201)
9. T. Kandabashi, H. Shimokawa, and K. Miyata Inhibition of myosin phosphatase by upregulated Rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1b Circulation 101 2000 1319 1323 (Pubitemid 30158621)
10. H. Shimokawa Cellular and molecular mechanisms of coronary artery spasm lessons from animal models Jpn Circ J 64 2000 1 12 (Pubitemid 30073654)
11. A. Masumoto, M. Mohri, H. Shimokawa, L. Urakami, M. Usui, and A. Takeshita Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina Circulation 105 2002 1545 1547 (Pubitemid 34297629)
12. M. Mohri, H. Shimokawa, Y. Hirakawa, A. Masumoto, and A. Takeshita Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm J Am Coll Cardiol 41 2003 15 19 (Pubitemid 36044397)
13. K. Oi, H. Shimokawa, and J. Hiroki Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic activity through upregulation of Rho-kinase Arterioscler Thromb Vasc Biol 24 2004 918 922 (Pubitemid 38620872)
14. T. Hizume, K. Morikawa, and A. Takaki Sustained elevation of serum cortisol level causes sensitization of coronary vasoconstricting responses in pigs in vivo: a possible link between stress and coronary vasospasm Circ Res 99 2006 767 775 (Pubitemid 44498310)
15. T. Ishizaki, M. Maekawa, and K. Fujisawa The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase EMBO J 15 1996 1885 1893 (Pubitemid 26119224)
16. M. Amano, K. Chihara, and K. Kimura Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase Science 275 1997 1308 1311 (Pubitemid 27114159)
17. H. Shimokawa, and A. Takeshita Rho-kinase is an important therapeutic target in cardiovascular medicine Arterioscler Thromb Vasc Biol 25 2005 1767 1775 (Pubitemid 41243442)
18. J.K. Liao, M. Seto, and K. Noma Rho kinase (ROCK) inhibitors J Cardiovasc Pharmacol 50 2007 17 24 (Pubitemid 47220442)
19. A. Nohria, M.E. Grunert, and Y. Rikitake Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease Circ Res 99 2006 1426 1432 (Pubitemid 44949679)
20. S.K. Feske, F.A. Sorond, and G.V. Henderson Increased leukocyte ROCK activity in patients after acute ischemic stroke Brain Res 1257 2009 89 93
21. Z. Do.e, Y. Fukumoto, and A. Takaki Evidence for Rho-kinase activation in pulmonary arterial hypertension Circ J 73 2009 1731 1739
22. T. Hidaka, T. Hata, and J. Soga Increased leukocyte Rho kinase (ROCK) activity and endothelial dysfunction in cigarette smokers Hypertens Res 33 2010 354 359
23. P.-Y. Liu, J.-H. Chen, L.-J. Lin, and J.K. Liao Increased Rho kinase activity in a Taiwanese population with metabolic syndrome J Am Coll Cardiol 49 2007 1619 1624 (Pubitemid 46551629)
24. T. Hata, J. Soga, and T. Hidaka Calcium channel blocker and rho-associated kinase activity in patients with hypertension J Hypertens 29 2011 373 379
25. M. Rashid, S. Tawara, Y. Fukumoto, M. Seto, K. Yano, and H. Shimokawa Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitors Circ J 73 2009 361 370
26. Japanese Society of Hypertension Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004) Hypertens Res 29 suppl 2006 S1 S105
27. Japan Diabetes Society of Guidelines for Treatment of Diabetes Mellitus 20062007 (in Japanese) 2006 Bunkodo Co., Ltd Hongo, Tokyo
28. Y. Saito Editorial: guidelines for diagnosis and treatment of atherosclerotic cardiovascular diseases 2002 J Atheroscler Thromb 11 2004 101 103
29. The Examination Committee of Criteria for "Obesity Disease" in Japan Japan Society for the Study of Obesity New criteria for "obesity disease" in Japan Circ J 66 2002 987 992
30. Y. Takagi, S. Yasuda, and J. Takahashi Importance of dual induction test for coronary vasospasm and ventricular fibrillation in patients surviving out-of-hospital cardiac arrest Circ J 73 2009 767 769
31. JCS Joint Working Group Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS2008): digest version Circ J 74 2010 1745 1762
32. P.Y. Liu, and J.K. Liao A method for measuring Rho kinase activity in tissue and cells Methods Enzymol 439 2008 181 189
33. H. Suzuki, S. Kawai, and T. Aizawa Histological evaluation of coronary plaque in patients with variant angina: relationship between vasospasm and neointimal hyperplasia in primary coronary lesions J Am Coll Cardiol 33 1999 198 205 (Pubitemid 29064093)
34. M.J. Hung, W.J. Cherng, N.I. Yang, C.W. Cheng, and L.F. Li Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease Am J Cardiol 96 2005 1484 1490
35. T. Itoh, Y. Mizuno, E. Harada, M. Yoshimura, H. Ogawa, and H. Yasue Coronary spasm is associated with chronic low-grade inflammation Circ J 71 2007 1074 1078 (Pubitemid 46998022)
36. T. Kandabashi, H. Shimokawa, and K. Miyata Evidence for protein kinase C-mediated activation of Rho-kinase in a porcine model of coronary artery spasm Arterioscler Thromb Vasc Biol 23 2003 2209 2214 (Pubitemid 37532322)
37. H. Yasue, H. Nakagawa, T. Itoh, E. Harada, and Y. Mizuno Coronary artery spasmclinical features, diagnosis, pathogenesis, and treatment J Cardiol 51 2008 2 17 (Pubitemid 351709406)
38. A. Buxton, S. Goldberg, and J.W. Hirshfeld Refractory ergonovine-induced coronary vasospasm: importance of intracoronary nitroglycerin Am J Cardiol 46 1980 329 334 (Pubitemid 10046354)
39. M.E. Bertrand, J.M. LaBlanche, and P.Y. Tilmant Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography Circulation 65 1982 1299 1306 (Pubitemid 12123620)
40. S. Sueda, H. Saeki, and T. Otani Major complications during spasm provocation tests with an intracoronary injection of acetylcholine Am J Cardiol 85 2000 391 394 (Pubitemid 30052918)